TLRY Tilray

Breckenridge Brewery and University of Colorado Athletics Collaborate on New Limited-Edition Craft Beer

Breckenridge Brewery and University of Colorado Athletics Collaborate on New Limited-Edition Craft Beer

The Co-branded ‘Juice Drop’ Hazy IPA is Now Available in 19.2oz Cans at Retailers Across Colorado

BRECKENRIDGE, Colo., Oct. 31, 2024 (GLOBE NEWSWIRE) -- , a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announced an exciting collaboration with the of Colorado Athletics to bring fans a special edition of its beloved in a new 19.2 oz. limited-edition can. This exciting partnership celebrates Colorado's rich traditions in both craft beer and collegiate athletics, offering Buffs fans the perfect way to enjoy game day in style. This exciting partnership celebrates Colorado's rich traditions in both craft beer and collegiate athletics, offering Buffs fans the perfect way to enjoy game day in style.



The new limited-edition can designs feature the iconic CU Buffaloes logo alongside Breckenridge Brewery’s Juice Drop Hazy IPA branding, making it a must-have collectible for both beer enthusiasts and Buffs supporters alike. With a bold, vibrant taste that perfectly embodies the Buffs’ spirit, Juice Drop's tropical, citrus-forward flavor profile is sure to be a hit at tailgates, watch parties, and more.

"We have proudly been the Buffs' craft beer partner for four years," stated Ryan Workman, the brand director at Breckenridge Brewery. "The process of creating a co-branded craft beer label with them has been a great experience. The Buffs boast an incredible fanbase, and our collaborative beer, Juice Drop, has now become one of our signature brews. This partnership has allowed us to bring our beer to Buffs fans in an enjoyable and unique way, combining our shared enthusiasm for CU athletics."

Breckenridge Brewery and Colorado Athletics worked closely to develop this partnership with athletics multimedia rights holder Buffalo Sports Properties, the locally based team of Learfield – the media and technology company powering college athletics – and CLC, a division of Learfield and Colorado’s exclusive trademark licensing agent.

The limited-edition Juice Drop Hazy IPA 19.2oz cans will be available for a short time only at select retailers across Colorado, including those in Boulder and surrounding areas. Fans are encouraged to grab their cans before they’re gone, and cheer on the Buffaloes football team this season. Sko Buffs!

About Breckenridge Brewery

Breckenridge Brewery has been an innovator in Colorado's craft beer scene since 1990, with a mission to create balanced, approachable, and interesting hand-crafted beers. The brewery's portfolio is a mix of unique seasonals, barrel-aged specialties, and classic go-to beers. Breckenridge Brewery prides itself on its connection to the community and its role in fostering a culture of beer appreciation. In addition to its new Juice Drop IPA limited-edition cans, Breckenridge has also released several other collaborative and notable partnerships that have become fan favorites including the – celebrating the Denver Nuggets’ history. For further information about Breckenridge Brewery, visit and follow @BreckBrew on social platforms.

About CU Boulder Athletics

The University of Colorado, located at the foot of the Rocky Mountains in Boulder, began intercollegiate competition in the spring of 1890, and 134 years later the school sponsors 17 varsity programs on the NCAA Division I level.  The school sponsors men's and women's basketball, men's and women's cross country, football, men's and women's golf, women's lacrosse, men's and women's skiing, women's soccer, women's tennis, men's and women's indoor and outdoor track & field, and women's volleyball.  Known as the Buffaloes since 1934, the school has won 30 national championships, over 200 conference championships and boasts more than 150 individual NCAA Champions.

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time – by inspiring and empowering a worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Tilray’s mission is to be the most responsible, trusted, and market-leading cannabis and consumer products company in the world with a portfolio of innovative, high-quality, and beloved brands that address the needs of the consumers, customers, and patients we serve. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages. For more information on how we open a world of well-being, visit   and follow @tilray on all social platforms.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

Tilray Brands Contacts:  Media:   

Investors:  

A photo accompanying this announcement is available at .



EN
31/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Ye...

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United States, today announced that it has entered into an exclusive licensing agreement starting January 1, 2027 with the Carlsberg Group, one of the world’s premier brewing organizations and among the largest globally by revenue. Under the terms of the agreement, Tilray has been granted a m...

 PRESS RELEASE

Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich...

Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich durch eine strategische Vereinbarung mit Smartway Pharmaceuticals CC-Pharma-Vereinbarung fördert das Wachstum von Tilray im Vereinigten Königreich und stärkt den Vertrieb über Apotheken- und Krankenhauskanäle NEW YORK und LONDON, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, die Pharmasparte von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), gab heute bekannt, dass ihr europäisches pharmazeutisches Vertriebsunternehmen CC Pharma eine strategische Vereinbarung mit , einem führenden pharmazeutischen Vertriebspartner...

 PRESS RELEASE

Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni g...

Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni grâce à un accord stratégique avec Smartway Pharmaceuticals L’accord avec CC Pharma renforce la croissance de Tilray au Royaume-Uni, consolidant sa distribution auprès des pharmacies et des hôpitaux NEW YORK et LONDRES, 13 févr. 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, la division pharmaceutique de Tilray Brands, Inc. (Nasdaq : TLRY ; TSX : TLRY), a annoncé aujourd'hui que son activité de distribution pharmaceutique européenne, CC Pharma, a conclu un accord stratégique avec , un partenaire de distribution pharmaceutique...

 PRESS RELEASE

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement wi...

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals CC Pharma Agreement Bolsters Tilray’s UK Growth, Strengthening Distribution to Pharmacy and Hospital Channels NEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that its European pharmaceutical distribution business, CC Pharma, has entered into a strategic agreement with , a leading UK-based pharmaceutical distribution partner, to expand the availability of pharmaceutical products...

 PRESS RELEASE

CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in De...

CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in Deutschland ausgezeichnet Die Auszeichnung würdigt CC Pharma als innovativen Marktführer und vertrauenswürdigen Partner auf dem europäischen Pharmamarkt DENSBORN, Deutschland, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, die Pharmasparte von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), gab heute bekannt, dass , ihr europäischer Pharmahändler, zu einem der ernannt wurde. Hierbei handelt es sich um eine der renommiertesten und unabhängigsten Auszeichnungen für Innovation bei kleinen und mittleren Unternehmen des La...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch